author-photo

Paul Klekotka

Eli Lilly and Company

9

Papers

463

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load.

2021 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

2021 JAMA
Show All
- Source
- Cite
- Save
Citations (310)
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.

2021 JAMA
Show All
- Source
- Cite
- Save
Citations (32)
First in Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients with COVID-19.

2021 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Randomised Phase 2 Study.

2019 British Journal of Dermatology
Show All
- Source
- Cite
- Save
Citations (43)
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (47)
Development of the Chronic Obstructive Pulmonary Disease Morning Symptom Diary (COPD-MSD)

2016 Health and Quality of Life Outcomes
Show All
- Source
- Cite
- Save
Citations (5)
Chronic Obstructive Pulmonary Disease Morning Symptom Diary

2016
Show All
- Source
- Cite
- Save
Citations (0)